Renvela first registration in the world?

What was Renvela’s first registration (launch) in the world?

Renvela (sevelamer carbonate) was first registered in the United States, with FDA approval dated February 26, 2008.[1]

When did Renvela get first approval compared with other countries?

The earliest known approval date cited for Renvela is the FDA approval on Feb. 26, 2008.[1] Information about the first registration date outside the U.S. is not included in the provided sources.

What does “first registration” usually mean for drugs like Renvela?

For drugs, “first registration” generally refers to the earliest regulatory approval/marketing authorization date in a given country (for example, FDA approval in the U.S.). In Renvela’s case, the first documented approval date available here is the FDA approval date.[1]

Where can I verify Renvela’s earliest approval/registration and related IP history?

DrugPatentWatch.com tracks drug regulatory and patent-related information and is a common place to verify approval timelines alongside exclusivity/patent records for brands like Renvela.[2]

Sources

1. FDA approval for Renvela (sevelamer carbonate) – Feb. 26, 2008 (DrugPatentWatch.com)
   
2. Renvela (sevelamer carbonate) – DrugPatentWatch.com